SCHEMBL4589168

SCHEMBL4589168

CCOC(=O)c1ccc(-c2nc(C(=O)OCC)c(C)n2-c2ccccc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.65
SIRT1 Q96EB6 2/20 0.65
HPGD P15428 2/20 0.56
HTT P42858 1/20 0.56
ALDH1A1 P00352 3/20 0.55
MAPT P10636 3/20 0.55
GAA P10253 1/20 0.55
GABRA2 P47869 4/20 0.53
GABRB2 P47870 4/20 0.53
RARA P10276 1/20 0.53
RARB P10826 1/20 0.53
RARG P13631 1/20 0.53
MEN1 O00255 1/20 0.53
BLM P54132 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TP53 P04637 1/20 0.52
ALOX12 P18054 1/20 0.52
KDM4E B2RXH2 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2681081 0.92 GABRA2 (0.58) SIRT2SIRT1HPGDALDH1A1MAPT
SCHEMBL1078509 0.82 TP53 (0.58) SIRT2SIRT1HPGDALDH1A1MAPT
SCHEMBL21760759 0.81 SIRT2 (0.74) SIRT2SIRT1HPGDHTTALDH1A1
SCHEMBL21749185 0.79 SIRT2 (0.61) SIRT2SIRT1HPGDHTTALDH1A1
SCHEMBL5783789 0.78 ALDH1A1 (0.51) HPGDALDH1A1MAPTGAAMEN1
SCHEMBL17414567 0.77 KDM1A (0.54) SIRT2SIRT1HPGDHTTALDH1A1
SCHEMBL6208711 0.76 TP53 (0.51) SIRT2SIRT1HPGDALDH1A1MAPT
SCHEMBL24106782 0.75 MEN1 (0.70) ALDH1A1MAPTGAARARARARB
SCHEMBL570961 0.75 MEN1 (0.70) ALDH1A1MAPTGAARARARARB
SCHEMBL6444855 0.75 SIRT2 (0.65) SIRT2SIRT1HPGDHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080009506-A1 Imidazole Compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2008-01-10 US disclosed
EP-1799650-A2 IMIDAZOLE DERIVATIVES AS LARGE CONDUCTANCE CALCIUM ACTIVATED K CHANNEL OPENERS TANABE SEIYAKU CO., LTD. (JP) 2007-06-27 EP disclosed
WO-2006030977-A2 IMIDAZOLE DERIVATIVES AS LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENERS TANABE SEIYAKU CO., LTD. (JP) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009506-A1 Imidazole Compound KCNH2, KCNJ2, KCNH3 SIRT2 1173/4885SIRT1 1155/4885HPGD 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.